Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

NCT01130025 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Warfarin
DRUG: Innohep®

Sponsor

LEO Pharma